Free Account Opening + AMC Free Demat
Loading...

Sotac Pharmaceuticals Limited IPO (Sotac Pharmaceuticals IPO) Detail

March 29, 2023 - April 3, 2023

Sotac Pharmaceuticals IPO is a book built issue of Rs 33.30 crores. The issue is entirely a fresh issue of 30 lakh shares.

Sotac Pharmaceuticals IPO bidding started from March 29, 2023 and ended on April 3, 2023. The allotment for Sotac Pharmaceuticals IPO was finalized on Monday, April 10, 2023. The shares got listed on NSE SME on April 13, 2023.

Sotac Pharmaceuticals IPO price band is set at ₹105 to ₹111 per share. The minimum lot size for an application is 1200 Shares. The minimum amount of investment required by retail investors is ₹133,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹266,400.

Beeline Capital Advisors Pvt Ltd is the book running lead manager of the Sotac Pharmaceuticals IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Sotac Pharmaceuticals IPO is Sunflower Broking.

Refer to Sotac Pharmaceuticals IPO RHP for detailed information.

Sotac Pharmaceuticals IPO Details

IPO Date March 29, 2023 to April 3, 2023
Listing Date April 13, 2023
Face Value ₹10 per share
Price Band ₹105 to ₹111 per share
Lot Size 1200 Shares
Total Issue Size3,000,000 shares
(aggregating up to ₹33.30 Cr)
Fresh Issue3,000,000 shares
(aggregating up to ₹33.30 Cr)
Issue Type Book Built Issue IPO
Listing At NSE SME
Share holding pre issue8,050,000
Share holding post issue11,050,000
Market Maker portion150,000 shares
Sunflower Broking

Sotac Pharmaceuticals IPO Reservation

Sotac Pharmaceuticals IPO offers 3,001,800 shares. 571,800 (19.05%) to QIB, 428,400 (14.27%) to NII, 998,400 (33.26%) to RII 853,200 (28.42%) to Anchor investors.

Investor Category Shares Offered
Anchor Investor Shares Offered853,200 (28.42%)
Market Maker Shares Offered150,000 (5.00%)
QIB Shares Offered571,800 (19.05%)
NII (HNI) Shares Offered428,400 (14.27%)
Retail Shares Offered998,400 (33.26%)
Total Shares Offered3,001,800 (100%)

Sotac Pharmaceuticals IPO Anchor Investors Details

Sotac Pharmaceuticals IPO raises Rs 9.47 crore from anchor investors. Sotac Pharmaceuticals IPO Anchor bid date is March 28, 2023. Sotac Pharmaceuticals IPO Anchor Investors list

Bid Date March 28, 2023
Shares Offered 853,200
Anchor Portion Size (In Cr.) 9.47
Anchor lock-in period end date for 50% shares (30 Days) May 10, 2023
Anchor lock-in period end date for remaining shares (90 Days) July 9, 2023

Sotac Pharmaceuticals IPO Timeline (Tentative Schedule)

Sotac Pharmaceuticals IPO opens on March 29, 2023, and closes on April 3, 2023.

IPO Open Date Wednesday, March 29, 2023
IPO Close Date Monday, April 3, 2023
Basis of Allotment Monday, April 10, 2023
Initiation of Refunds Tuesday, April 11, 2023
Credit of Shares to Demat Wednesday, April 12, 2023
Listing Date Thursday, April 13, 2023
Cut-off time for UPI mandate confirmation 5 PM on April 3, 2023

Sotac Pharmaceuticals IPO Lot Size

Investors can bid for a minimum of 1200 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 1200 ₹133,200
Retail (Max) 1 1200 ₹133,200
HNI (Min) 2 2,400 ₹266,400
Lot Size Calculator

Sotac Pharmaceuticals IPO Promoter Holding

Mr. Sharadkumar Dashrathbhai Patel, Mr. Dineshkumar Babulal Gelot, Mr. Vishalkumar Devrajbhai Patel, Mr. Chetankumar Bachubhai Patel, and Mrs. Kiran Baldevbhai Jotania are the promoters of the company.

Share Holding Pre Issue 84.63%
Share Holding Post Issue

About Sotac Pharmaceuticals Limited

Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.

SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.

Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.

With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.

Company Financials

Sotac Pharmaceuticals Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-203,038.212,882.648.75305.7375.7315.13
31-Mar-213,469.754,894.97-236.54249.3619.361,035.80
31-Mar-223,525.357,337.02287.86662.19432.191,134.59
30-Sep-226,461.603,994.6546.55797.41567.412,185.52
Amount in ₹ Lakhs

Key Performance Indicator

The market capitalization of Sotac Pharmaceuticals IPO is Rs 122.66 Cr.

KPI Values
ROE6.38%
ROCE19.03%
Debt/Equity2.74
Pre IPO Post IPO
P/E (x) 132.14

Objects of the Issue (Sotac Pharmaceuticals IPO Objectives)

The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:

  1. To Meet Working Capital Requirements
  2. Investment in Subsidiary
  3. Upgradation / Construction of Existing /New Building in the Existing Premises
  4. General Corporate Purpose
  5. To meet Public Issue Expenses

Sotac Pharmaceuticals IPO Review (Avoid)

[Dilip Davda]  This pharma/healthcare segment company has marked wild fluctuations in its bottom lines for the reported periods. Based on FY23 annualized earnings, the issue appears exorbitantly priced. It is operating in a highly competitive and fragmented segment. SPL’s debt level is also higher and raises concerns. There is no harm in skipping this pricey bet. Read detail review...


Sotac Pharmaceuticals IPO Subscription Status (Bidding Detail)

The Sotac Pharmaceuticals IPO is subscribed 1.60 times on April 3, 2023 7:30:00 PM. The public issue subscribed 0.91 times in the retail category, 1.00 times in the QIB category, and 4.04 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)
QIB1.00
NII4.04
Retail0.91
Total1.60

Total Application : 755 (1.30 times)

Sotac Pharmaceuticals IPO Prospectus

Sotac Pharmaceuticals IPO Rating

10
3.5
Rating:Rated 3.5 stars
Vote Here ...

Sotac Pharmaceuticals IPO Listing Details

Listing Date April 13, 2023
BSE Script Code
NSE Symbol SOTAC
ISIN INE0O2D01012
Final Issue Price ₹111 per share

Pre-Open Session - NSE

Listing Day Trading Information

Price Details
Final Issue Price
Open
Low
High
Last Trade
NSE SME
₹111.00
₹115.00
₹115.00
₹120.75
₹120.75

Check IPO Performance…

Sotac Pharmaceuticals Limited Contact Details

Sotac Pharmaceuticals Limited
Plot No. PF-21, Nr. ACME Pharma,
Opp. Teva Pharma Sanand GIDC-II,
Sanand Ahmedabad - 382110
Phone: +91 90819 93300
Email: compliance@sotacpharma.com
Website: http://www.sotacpharma.com/

Sotac Pharmaceuticals IPO Registrar

Kfin Technologies Limited

Phone: 04067162222, 04079611000
Email: sotac.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/

Sotac Pharmaceuticals IPO - Buy or Not

Sotac Pharmaceuticals IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 0 0 1
Members 2 0 1

Read All Reviews Post Your Review Manage Reviews

SME IPO Enquiry

SME Company Owners
We could help you get listed on the stock market.

Contact us Today

Check our SME IPO Guide New

Sotac Pharmaceuticals IPO FAQs

Sotac Pharmaceuticals IPO is a SME IPO of 3,000,000 equity shares of the face value of ₹10 aggregating up to ₹33.30 Crores. The issue is priced at ₹105 to ₹111 per share. The minimum order quantity is 1200 Shares.

The IPO opens on March 29, 2023, and closes on April 3, 2023.

Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Zerodha customers can apply online in Sotac Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Sotac Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Sotac Pharmaceuticals IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Sotac Pharmaceuticals IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Sotac Pharmaceuticals IPO opens on March 29, 2023 and closes on April 3, 2023.

Sotac Pharmaceuticals IPO lot size is 1200 Shares, and the minimum amount required is ₹133,200.

You can apply in Sotac Pharmaceuticals IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Sotac Pharmaceuticals IPO will be done on Monday, April 10, 2023, and the allotted shares will be credited to your demat account by Wednesday, April 12, 2023. Check the Sotac Pharmaceuticals IPO allotment status.

The Sotac Pharmaceuticals IPO listing date is on April 13, 2023.
Open an Instant Account with Zerodha

Sotac Pharmaceuticals IPO Message Board

Ranked Members of Chittorgarh.com Forum  Ranked Members | Members with Most Likes

Loading...

92 Comments

66. Gaurav DD dimer |   Link |  Bookmark |May 20, 2023 3:19:59 PM
IPO Mentor IPO Mentor (1200+ Posts, 400+ Likes)
Results on 29th May
65. 🎯 Big Bull 🎯 |   Link |  Bookmark |May 7, 2023 12:55:15 AM
IPO Guru IPO Guru (1000+ Posts, 700+ Likes)
Mankind Final Listing Date 9 may 2023 Tuesday
64. Silent |   Link |  Bookmark |April 14, 2023 8:32:48 AM
Heading for another couple of UCs. Bulk deal shows good buying by couple of funds. I am going to hold my two lots for now.
63. Small Investor |   Link |  Bookmark |April 13, 2023 2:48:45 PM
IPO Guru IPO Guru (2200+ Posts, 1100+ Likes)
also hold all 4 lot for more profit
62. Dinesh Singh |   Link |  Bookmark |April 13, 2023 11:15:28 AM
IPO Guru IPO Guru (1300+ Posts, 500+ Likes)
Sold 2 lot @ 120.75 and holding 1 lot.
61. sahab |   Link |  Bookmark |April 13, 2023 10:34:54 AM
IPO Guru IPO Guru (1100+ Posts, 600+ Likes)
Going for positive listing till now
60. ARJUN'S EYE |   Link |  Bookmark |April 13, 2023 10:13:38 AM
IPO Mentor IPO Mentor (900+ Posts, 800+ Likes)
Today Listing Sotac Pharmaceuticals Ltd. NSE SME IPO.
Code:-15004
Symbol:-SOTAC
Group:-ST
ISIN:-INE0O2D01012
Issue Price:-111/-
Market Lot:-1200 Shares
Face Value:-10/-
Listing At:-NSE SME
59. Justalearner |   Link |  Bookmark |April 12, 2023 8:27:44 PM
IPO Mentor IPO Mentor (700+ Posts, 500+ Likes)
The listing seems to be heading for a good positive figure.
Background works being done aggressively.
Chances of negative listing highly unlikely, although not very sure of the info....
All the best to the allottees.
PS: I had skipped it. Didn't like the company profile.
59.2. Justalearner |   Link |  Bookmark |April 12, 2023 10:23:28 PM
IPO Mentor IPO Mentor (700+ Posts, 500+ Likes)
@Dinesh Singh 
All the best for tomorrow. May all the public allottees make handsome profits.
59.3. Dinesh Singh |   Link |  Bookmark |April 13, 2023 11:04:56 AM
IPO Guru IPO Guru (1300+ Posts, 500+ Likes)
Sold 2 lot @ 120.75. Holding 1 lot.
58. Vnrao |   Link |  Bookmark |April 11, 2023 9:39:12 PM
Top Contributor Top Contributor (500+ Posts, 200+ Likes)
Good Luck to all allottees. Market mood significantly improved since the IPO. Positive listing expected.
57. Silent |   Link |  Bookmark |April 11, 2023 6:30:26 PM
Allotment recieved. Fingers crossed
56. SJogi |   Link |  Bookmark |April 11, 2023 12:41:24 PM
IPO Guru IPO Guru (1100+ Posts, 900+ Likes)
just want to see what happens to this stock which is at a PE of 132.
surprised to see the subscription data.
55. Raghu Shende |   Link |  Bookmark |April 11, 2023 10:37:59 AM
It may list with little premium
55.1. Raghu Shende |   Link |  Bookmark |April 13, 2023 11:06:27 AM
As i said it listed with 4 points premium.
1200*4=4800/- per lot
54. Baron |   Link |  Bookmark |April 6, 2023 8:08:56 PM
will list flat or negative
54.1. Raju Ango |   Link |  Bookmark |April 7, 2023 10:43:53 PM
Good sir baron
53. Silent |   Link |  Bookmark |April 4, 2023 9:05:45 AM
Three anchor investors bided for entire anchor quota. One Dubai based and two Mauritius based firms.
52. IPOmentor |   Link |  Bookmark |April 3, 2023 5:04:29 PM (200+ Posts)
Finally they do it. Firm allotment for retailers. Best of luck for positive listing
51. Gaurav DD dimer |   Link |  Bookmark |April 3, 2023 4:51:17 PM
IPO Mentor IPO Mentor (1200+ Posts, 400+ Likes)
Skipped

May list at Par/Positive by operators, but fundamentally not worth investing.
50. Silent |   Link |  Bookmark |April 3, 2023 4:10:25 PM
I am taking plunge solely based on promoters and not bothering about valuations. Promoters are genuine and dedicated.
49. Keshav Kumar |   Link |  Bookmark |April 3, 2023 2:10:08 PM
I also apply 5 Retail applications.
48. Anil Mwt |   Link |  Bookmark |April 3, 2023 1:01:58 PM
Top Contributor Top Contributor (400+ Posts, 100+ Likes)
No means “No”
47. ipo share |   Link |  Bookmark |April 3, 2023 12:54:08 PM
IPO Guru IPO Guru (1600+ Posts, 800+ Likes)
After shocking listing of USK, nobody is even bothered to discuss about this IPO and quite natural reaction.